These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783 [TBL] [Abstract][Full Text] [Related]
25. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. Le Goffic R; Balloy V; Lagranderie M; Alexopoulou L; Escriou N; Flavell R; Chignard M; Si-Tahar M PLoS Pathog; 2006 Jun; 2(6):e53. PubMed ID: 16789835 [TBL] [Abstract][Full Text] [Related]
26. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. Nagai T; Yamada H Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672 [TBL] [Abstract][Full Text] [Related]
27. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Kris RM; Yetter RA; Cogliano R; Ramphal R; Small PA Immunology; 1988 Mar; 63(3):349-53. PubMed ID: 2832312 [TBL] [Abstract][Full Text] [Related]
28. The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus. Kim HM; Kang YM; Ku KB; Park EH; Yum J; Kim JC; Jin SY; Lee JS; Kim HS; Seo SH Virology; 2013 Sep; 444(1-2):394-403. PubMed ID: 23890814 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacologic ascorbate treatment of influenza in vivo]. Cheng L; Liu Y; Li B; Ye F; Ran P Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):356-9. PubMed ID: 25011511 [TBL] [Abstract][Full Text] [Related]
30. A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity. Even-Or O; Joseph A; Itskovitz-Cooper N; Samira S; Rochlin E; Eliyahu H; Goldwaser I; Balasingam S; Mann AJ; Lambkin-Williams R; Kedar E; Barenholz Y Vaccine; 2011 Mar; 29(13):2474-86. PubMed ID: 21251901 [TBL] [Abstract][Full Text] [Related]
31. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
32. Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice. Kurokawa M; Watanabe W; Shimizu T; Sawamura R; Shiraki K Antiviral Res; 2010 Feb; 85(2):373-80. PubMed ID: 19913056 [TBL] [Abstract][Full Text] [Related]
33. Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice. Wu J; Wang F; Fang F; Zhang W; Chang H; Zheng L; Chen Z Arch Virol; 2011 Mar; 156(3):387-95. PubMed ID: 21110049 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic effect of a Beta vulgaris extract on experimental influenza infection in mice. Prahoveanu E; Eşanu V; Anton G; Frunzulică S Virologie; 1986; 37(2):121-3. PubMed ID: 3727395 [TBL] [Abstract][Full Text] [Related]
35. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000 [TBL] [Abstract][Full Text] [Related]
36. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340 [TBL] [Abstract][Full Text] [Related]
37. Intratracheal administration of influenza virus is superior to intranasal administration as a model of acute lung injury. Morales-Nebreda L; Chi M; Lecuona E; Chandel NS; Dada LA; Ridge K; Soberanes S; Nigdelioglu R; Sznajder JI; Mutlu GM; Budinger GR; Radigan KA J Virol Methods; 2014 Dec; 209():116-20. PubMed ID: 25239366 [TBL] [Abstract][Full Text] [Related]
38. Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice. Vollmer AH; Gebre MS; Barnard DL Antiviral Res; 2016 Sep; 133():196-207. PubMed ID: 27523492 [TBL] [Abstract][Full Text] [Related]
39. Pretreatment of mice with oligonucleotide prop5 protects them from influenza virus infections. Li K; Zhou Z; Wang YO; Liu J; Zhao HB; Yang J; Wang SQ Viruses; 2014 Feb; 6(2):573-81. PubMed ID: 24509810 [TBL] [Abstract][Full Text] [Related]
40. Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Kechaou N; Chain F; Gratadoux JJ; Blugeon S; Bertho N; Chevalier C; Le Goffic R; Courau S; Molimard P; Chatel JM; Langella P; Bermúdez-Humarán LG Appl Environ Microbiol; 2013 Mar; 79(5):1491-9. PubMed ID: 23263960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]